Aberrant expression and function of p53 in T-cells immortalized by HTLV-I Tax1

FEBS Letters

Volumn 406, Issue 3, 1997, Pages 263-266

  Akagi, Tsuyoshi ^a   Ono, Hiroaki ^a   Tsuchida, Nobuo ^b   Shimotohno, Kunitada ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

HTLV I; p53; Tax1; Transactivation; Transcription

Indexed keywords

PROTEIN P53;

ARTICLE; CELL CULTURE; CELL IMMORTALIZATION; CONTROLLED STUDY; CYTOCHEMISTRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOPRECIPITATION; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSACTIVATION;

CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JURKAT CELLS; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0030985659     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(97)00280-9     Document Type: Article

References (28)

1. Franchini G. Blood. 86:1995;3619-3639.
2. Hollsberg P., Hafler D.A. New Engl J Med. 328:1993;1173-1182.
3. Feuer G., Chen I.S. Biochim Biophys Acta. 1114:1992;223-233.
4. Yoshida M. Trends Microbiol. 1:1993;131-135.
5. Akagi T., Shimotohno K. J Virol. 67:1993;1211-1217.
6. Grassmann R., Berchtold S., Radant I., Alt M., Fleckenstein B., Sodroski J.G., Haseltine W.A., Ramstedt U. J Virol. 66:1992;4570-4575.
7. Akagi T., Ono H., Shimotohno K. Blood. 86:1995;4243-4249.
8. Reid R.L., Lindholm P.F., Mireskandari A., Dittmer J., Brady J.N. Oncogene. 8:1993;3029-3036.
9. Yamato K., Oka T., Hiroi M., Iwahara Y., Sugito S., Tsuchida N., Miyoshi I. Jpn J Cancer Res. 84:1993;4-8.
10. Gartenhaus R.B., Wang P. Leukemia. 9:1995;2082-2086.
11. Cereseto A., Diella F., Mulloy J.C., Cara A., Michieli P., Grassmann R., Franchini G., Klotman M.E. Blood. 88:1996;1551-1560.
12. Miyoshi I., Kubonishi I., Yoshimoto S., Akagi T., Ohtsuki Y., Shiraishi Y., Nagata K., Hinuma Y. Nature. 294:1981;770-771.
13. Cheng J., Haas M. Mol Cell Biol. 10:1990;5502-5509.
14. Yamato K., Yamamoto M., Hirano Y., Tsuchida N. Oncogene. 11:1995;1-6.
15. Banks L., Matlashewski G., Crawford L. Eur J Biochem. 159:1986;529-534.
16. Gannon J.V., Greaves R., Iggo R., Lane D.P. EMBO J. 9:1990;1595-1602.
17. Cook A., Milner J. Br J Cancer. 61:1990;548-552.
18. Harlow E., Williamson N.M., Ralston R., Helfman D.M., Adams T.E. Mol Cell Biol. 5:1985;1601-1610.
19. Kiyono T., Hiraiwa A., Ishii S., Takahashi T., Ishibashi M. J Virol. 68:1994;4656-4661.
20. Hirano Y., Yamato K., Tsuchida N. Oncogene. 10:1995;1879-1885.
21. Subler M.A., Martin D.W., Deb S. Oncogene. 9:1994;1351-1359.
22. Bischoff F.Z., Yim S.O., Pathak S., Grant G., Siciliano M.J., Giovanella B.C., Strong L.C., Tainsky M.A. Cancer Res. 50:1990;7979-7984.
23. Shay J.W., Wright W.E., Werbin H. Biochim Biophys Acta. 1072:1991;1-7.
24. Harvey D.M., Levine A.J. Genes Dev. 5:1991;2375-2385.
25. Harvey M., et al. Oncogene. 8:1993;2457-2467.
26. Tsukada T., et al. Oncogene. 8:1993;3313-3322.
27. Finlay C.A. BioEssays. 14:1992;557-560.
28. Vousden K.H. Semin Cancer Biol. 6:1995;109-116.